Sentence ID	Sentence
246	The relative risks between highest and lowest quarters of PROTEIN1 intake adjusted for age, smoking, serum PROTEIN2 concentration, blood pressure, and body mass index were 0.69 (95% confidence interval 0.53 to 0.90) and 0.54 (0.33 to 0.87) for total and coronary mortality, respectively
247	Correlation between the stimulatory effect of PROTEIN1 on the formation of PROTEIN2 and the oxytocin receptor level in the pregnant rabbit myometrium
248	OBJECTIVE: In order to elucidate the roles of PROTEIN1 (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of PROTEIN2 induced by PROTEIN and the OT receptor levels were determined in rabbit myometria before and after parturition
249	OBJECTIVE: In order to elucidate the roles of PROTEIN1 (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of PROTEIN induced by PROTEIN2 and the OT receptor levels were determined in rabbit myometria before and after parturition
250	OBJECTIVE: In order to elucidate the roles of PROTEIN (IP3) and oxytocin (OT) receptors in rabbit parturition, the concentration of PROTEIN1 induced by PROTEIN2 and the OT receptor levels were determined in rabbit myometria before and after parturition
251	METHODS: The effects of PROTEIN1 on PROTEIN2 formation and OT receptor levels were determined in the myometria of non-pregnant rabbits, Days 26, 28 and 30 of pregnancy rabbits, postpartum rabbits within 12 hours and steroid-treated ovariectomized rabbits
252	RESULTS: OT receptors were not detectable in the myometria of non-pregnant rabbits, and PROTEIN1 had no effect on the formation of PROTEIN2 (IPs)
253	On Day 28 of pregnancy, OT receptors became detectable, and then PROTEIN1 could induce the formation of PROTEIN2 
254	Thereafter, the stimulatory effects of PROTEIN1 on PROTEIN2 formation and the OT receptor levels dramatically increased toward the end of pregnancy and reduced rapidly after parturition
255	When the ovariectomized pregnant rabbits were treated with estrogen, OT receptors in the myometrium were induced, and PROTEIN1 acquired the ability to stimulate PROTEIN2 formation
256	In addition, an OT receptor antagonist inhibited the stimulatory effects of PROTEIN1 on PROTEIN2 formation
257	CONCLUSIONS: These results suggest that the formation of PROTEIN1 by PROTEIN2 the OT receptor levels in the myometrium, and the production of PGF2 in the decidua might play crucial roles in parturition
258	Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and PROTEIN1 and the PROTEIN response to PROTEIN2 induced hypoglycemia
259	Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and PROTEIN and the PROTEIN1 response to PROTEIN2 induced hypoglycemia
260	Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and PROTEIN1 and the PROTEIN2 response to PROTEIN induced hypoglycemia
261	To explore the possible roles of the hypothalamic melanocortin system in PROTEIN1 action, we examined the effects of intracerebroventricular (i.c.v.) injection of PROTEIN with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial PROTEIN2 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats
262	To explore the possible roles of the hypothalamic melanocortin system in PROTEIN1 action, we examined the effects of intracerebroventricular (i.c.v.) injection of PROTEIN2 with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial PROTEIN (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats
263	To explore the possible roles of the hypothalamic melanocortin system in PROTEIN action, we examined the effects of intracerebroventricular (i.c.v.) injection of PROTEIN1 with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial PROTEIN2 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats
264	A single i.c.v. injection of PROTEIN1 decreased cumulative food intake and body weight gain, and increased PROTEIN2 mRNA expression during 3 h at the onset of the dark phase
265	Co-injection of SHU9119 also inhibited completely the PROTEIN1 induced increase in PROTEIN2 mRNA expression in the BAT
266	It has been established that PROTEIN1 beta peptide (AbetaP) activates phospholipase A2, PROTEIN2 and phospholipase D of LA-N-2 cells and other cell types
267	(-)Nicotine did not blunt the PROTEIN1 activation of PROTEIN2 
268	The specific PROTEIN1 (PKC) inhibitor chelerythrine (5 micrometers) inhibited PTH-, PROTEIN2 , PGE2-, and adenosine-stimulated Ca2+ reabsorption by 77%, 67%, 79%, and 100%, respectively
269	CONCLUSION: PTH, PROTEIN1 PGE2, and adenosine stimulate Ca2+ reabsorption via a pathway that is independent of cAMP and that involves a phorbol ester-insensitive PROTEIN2 isotype
270	The experiments were concluded by taking blood samples for later analysis of plasma glucose and plasma levels of the following hormones: PROTEIN1 gastrin, CCK, glucagon, somatostatin, PROTEIN2 and corticosterone
271	The low-performing Stock B animals were characterized by [1] being more reactive to sensory stimulation: higher startle amplitude and shorter startle latency; [2] having higher plasma PROTEIN1 and corticosterone levels, whereas plasma gastrin and PROTEIN2 were significantly lowered and a strong tendency for a decrease also in plasma CCK
272	The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN2 resulted in induction of the uterine PROTEIN and PROTEIN levels
273	The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN2 resulted in induction of the uterine PROTEIN and PROTEIN levels
274	The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN1 mRNA expression and exogenous administration of PROTEIN2 resulted in induction of the uterine PROTEIN and PROTEIN levels
275	The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN1 resulted in induction of the uterine PROTEIN and PROTEIN2 levels
276	The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN1 resulted in induction of the uterine PROTEIN2 and PROTEIN levels
277	The expression of uterine PROTEIN1 and PROTEIN2 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN levels
278	The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN2 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN levels
279	The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN2 levels
280	The expression of uterine PROTEIN and PROTEIN1 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN2 and PROTEIN levels
281	The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN2 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN levels
282	The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN2 levels
283	The expression of uterine PROTEIN1 and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN2 and PROTEIN levels
284	The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN1 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN and PROTEIN2 levels
285	The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN1 mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN2 and PROTEIN levels
286	The expression of uterine PROTEIN and PROTEIN were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT PROTEIN mRNA expression and exogenous administration of PROTEIN resulted in induction of the uterine PROTEIN1 and PROTEIN2 levels
287	These results indicate that PROTEIN gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN1 and PROTEIN2 mRNA may be due to increased PROTEIN levels
288	These results indicate that PROTEIN gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN and PROTEIN1 mRNA may be due to increased PROTEIN2 levels
289	These results indicate that PROTEIN1 gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN and PROTEIN2 mRNA may be due to increased PROTEIN levels
290	These results indicate that PROTEIN gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN1 and PROTEIN mRNA may be due to increased PROTEIN2 levels
291	These results indicate that PROTEIN1 gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN2 and PROTEIN mRNA may be due to increased PROTEIN levels
292	These results indicate that PROTEIN1 gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine PROTEIN and PROTEIN mRNA may be due to increased PROTEIN2 levels
293	 PROTEIN1 (AVP) and lysophosphatidic acid (LPA) have been shown to stimulate PROTEIN2 (PKC) and mitogen-activated protein (MAP) kinases and the proliferation of vascular smooth muscle cells
294	However, PROTEIN1 induced activation of RSK2, a downstream substrate of ERK1 and ERK2, was PROTEIN2 dependent and PI 3-kinase-independent
